{"url_path":"/sec/sgmo/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1001233/0001628280-26-035067-index.html","accession_number":"0001628280-26-035067","cik":"0001001233","ticker":"SGMO","issuer_name":"SANGAMO THERAPEUTICS, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1001233/0001628280-26-035067-index.html","primary_entity_key":"0001001233","primary_entity_name":"SANGAMO THERAPEUTICS, INC"},"word_count":8,"has_tables":true,"body_markdown":"ITEM  5.    OTHER INFORMATION\n\nNone.\n\n37\n\n[Table of](#i37464b938c124fd1bcf924f2adb6d3e2_7)[Contents](#i37464b938c124fd1bcf924f2adb6d3e2_7)"}